From tomorrow morning till Friday evening, Nagi Bioscience will attend the Hello Tomorrow Summit in Paris as one of the World’s TOP500 Deep-Tech Startups. We are glad to be one of the startups selected for a showcase of our technology during this event. Come to visit us at booth #14 on Friday morning and seeRead more about Nagi Bioscience at the Hello Tomorrow Summit in Paris[…]
We are delighted to announce that our team will pitch the technology developed by Nagi Bioscience during the ILMAC Lausanne exhibition on Thursday, the 5th of October. The first-ever edition of ILMAC LAUSANNE is taking place on October 4 and 5, as the unique exhibition platform for the chemistry and life science community in the French-speaking partRead more about Our technology will be presented at ILMAC Lausanne 2017[…]
From September 10th to 13th, Nagi Bioscience attended the 53rd Congress of the European Societies of Toxicology (EuroTox) in Bratislava. Our team presented for the first time a poster with the latest results obtained in collaboration with Debiopharm SA.
We are delighted to announce that Nagi Bioscience has been chosen by Hello Tomorrow as one of the world’s TOP 500 deep-tech startups! Hello Tomorrow is a global not-for-profit organization created by deep tech entrepreneurs, with a mission to empower and connect the most promising deep-tech entreprises across the globe to accelerate the transfer of breakthrough technologies into real worldRead more about We made it to the TOP 500 in the Hello Tomorrow Global Challenge![…]
We are happy to announce the release of a new publication in collaboration with the Laboratory of Prof. Robin Gasser from the University of Melbourne. The article issued today in the FASEB Journal shows that deguelin, a plant-derived rotenoid, selectively and potently inhibits motility and development of nematodes, which supports its potential as a lead candidate for drugRead more about A collaborative study between the University of Melbourne (Prof. Gasser’s Lab) and the Nagi Bioscience team was published today[…]
In 2015, the project developed by Nagi Bioscience was the first recipient of the SGV 25th Fund. This fund was created by the SGV board to financially support projects related to the goals of the SGV, that are promotion of the Laboratory Animal Science and the Animal Welfare, and ethical considerations in animal experimentation. Read moreRead more about The platform developed by Nagi Bioscience is featured on the website of the Swiss Laboratory Animal Association (SGV)[…]
Gebert Rüf Stiftung fosters innovations for the benefit of Swiss economy and society, by supporting application-oriented and impact-oriented scientific projects at Swiss universities. The “Nematrix Project”, by Nagi Bioscience, became part of the GRS-supported project portfolio in November 2016.
The EPFL website and the Swiss French Radio (RTS) have covered the publication of our last scientific paper. The article was published in Molecular Neurodegeneration and shows data about the in vivo analysis of the long-term dynamics of protein aggregation in C. elegans at unprecedented resolution.
Our Business Idea (formerly known as Nematrix) was selected by the Jury Committee of >>venture>> 2015,out of a total of 107 submissions, as a TOP 10 winner of the business idea competition! The award ceremony took place at ETH Zurich in June 2015.